ComparisonInterventions

Citicoline vs Alpha-GPC

Two choline donors — one better evidenced, one with a safety question

Alpha-GPCAlpha-glycerophosphocholine

Last reviewed: July 2026
Version: 1.0
Review cadence: Annually

At a Glance

The 30-second view

Human evidence
Citicoline
More (mixed; mostly in impairment)
Alpha-GPC
Limited and low quality
Large trial result
Citicoline
ICTUS (stroke) was null
Alpha-GPC
None
Safety signal
Citicoline
None notable
Alpha-GPC
Observational stroke-risk association (unresolved)
Healthy-adult enhancement
Citicoline
Not established
Alpha-GPC
Not established
Dementia prevention
Citicoline
Insufficient evidence
Alpha-GPC
Insufficient evidence

Dimension	Citicoline	Alpha-GPC
Human evidence	More (mixed; mostly in impairment)	Limited and low quality
Large trial result	ICTUS (stroke) was null	None
Safety signal	None notable	Observational stroke-risk association (unresolved)
Healthy-adult enhancement	Not established	Not established
Dementia prevention	Insufficient evidence	Insufficient evidence

Overview

Both supply choline and are marketed for cognition. Citicoline has considerably more human research (concentrated in vascular cognitive impairment and stroke); alpha-GPC has limited efficacy evidence and an unresolved safety question.

Quick summary

If choosing between them, citicoline is the better-evidenced option — though that is a low bar, its results are mixed, and a large stroke trial was null. Alpha-GPC has weaker efficacy evidence plus an observational signal associating it with higher stroke risk, which is unconfirmed but unresolved. Neither enhances cognition in healthy adults, and neither prevents dementia.

When each is appropriate

Choose Citicoline

If a choline-donor supplement is being considered at all, citicoline is the better-evidenced choice.

Choose Alpha-GPC

Hard to justify: weak benefit evidence combined with an unresolved stroke-risk signal.

Evidence comparison

Volume of human evidence
Citicoline
Moderate (mixed)
Alpha-GPC
Limited
Population studied
Citicoline
Mostly cognitive impairment / stroke
Alpha-GPC
Small studies; cognition and athletic power
Large RCT
Citicoline
ICTUS — null
Alpha-GPC
None
Healthy-adult benefit
Citicoline
Not established
Alpha-GPC
Not established

Dimension	Citicoline	Alpha-GPC
Volume of human evidence	Moderate (mixed)	Limited
Population studied	Mostly cognitive impairment / stroke	Small studies; cognition and athletic power
Large RCT	ICTUS — null	None
Healthy-adult benefit	Not established	Not established

Safety comparison

Tolerability
Citicoline
Well tolerated
Alpha-GPC
Usually tolerated short-term
Safety signal
Citicoline
None notable
Alpha-GPC
Observational association with increased stroke risk (unconfirmed)

Dimension	Citicoline	Alpha-GPC
Tolerability	Well tolerated	Usually tolerated short-term
Safety signal	None notable	Observational association with increased stroke risk (unconfirmed)

Strengths & limitations

Citicoline

Most human evidence of the popular nootropics

Well tolerated

Used clinically in some countries

Mixed results; large stroke trial null

No healthy-adult enhancement evidence

Alpha-GPC

Raises choline availability

Some athletic-performance interest

Weak efficacy evidence

Unresolved stroke-risk association

Not guideline-supported

Frequently asked questions

Which choline supplement should I take for my brain?

Honestly — probably neither. Citicoline is the better-evidenced of the two, but the evidence is mixed and concentrated in impaired populations, and alpha-GPC carries an unresolved stroke-risk signal. Blood pressure, exercise, sleep, and hearing do vastly more for your brain.

Continue Exploring

Where to go next

References & sources

ICTUS trial (citicoline, null)
Alpha-GPC observational stroke analysis
Citicoline reviews

Comparisons synthesize BioSignal's existing calibrated evidence — they introduce no new conclusions. Figures and verdicts trace to the linked Signal Records and Foundations.

Educational information — not medical advice

Comparisons orient a decision; they don't make it for you. Choices between medications, supplements, or programs belong with a qualified clinician. See our Medical Disclaimer.

Is this comparison clear, balanced, and useful? Your feedback shapes what we review next.

Give feedback